Findings underscore strength of Natera’s technology for early cancer detection (ECD) Earlier in 2025, Natera reported preliminary AA performance data from a pilot study with 18% sensitivity and 91% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback